Google to loosen pharma ad rules for AdMob authorized buyers

Google will update its Pharmaceutical policy for AdMob Authorized Buyers in January 2026, allowing prescription drug and prescription drug service ads in select markets — without requiring Google certification — while tightening clarity around what remains strictly off-limits.

What’s changing. The policy will be renamed “Pharmaceutical products and services” and updated to allow Authorized Buyers to promote prescription drugs and prescription drug services in certain countries where permitted by local law, without requiring Google certification as is typically mandated in Google Ads.

While access is expanding, the underlying rules are not becoming more permissive, as the policy language is simply being reorganized to improve clarity and readability rather than to loosen enforcement.

Why we care. This update expands access to pharmaceutical advertising inventory without requiring Google certification, creating new reach and competitive pressure…